Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy.
about
An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancerEmerging critical role of molecular testing in diagnostic genitourinary pathologyIdentification of gene expression signature modulated by nicotinamide in a mouse bladder cancer modelS6K1 and 4E-BP1 are independent regulated and control cellular growth in bladder cancerThe role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder.Phosphorylated p70S6K in noninvasive low-grade urothelial carcinoma of the bladder: correlation with tumor recurrence.Biomarkers for bladder cancer management: present and future.Role of the mTOR Pathway in the Progression and Recurrence of Bladder Cancer: An Immunohistochemical Tissue Microarray Study.Biomarkers for prognosis and treatment selection in advanced bladder cancer patients.Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies.Dysregulation of mammalian target of rapamycin pathway in plasmacytoid variant of urothelial carcinoma of the urinary bladderCurrent status of molecular markers for prognostication and outcome in invasive bladder cancer.Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis.Akt activation correlates with the tumor aggressiveness in Tunisian patients with bladder cancer.Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: a tissue microarray study of 112 cases.Immunohistochemical Investigation of HER/AKT/mTOR Pathway and Cellular Adhesion Molecules in Urothelial Carcinomas.Phospho-mTOR in non-tumour and tumour bladder urothelium: Pattern of expression and impact on urothelial bladder cancer patients.Overexpression of DJ-1 and HSP90α, and loss of PTEN associated with invasive urothelial carcinoma of urinary bladder: Possible prognostic markers.Synthetic regulatory RNAs selectively suppress the progression of bladder cancer.Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder.Upregulation of Arp2 expression is associated with the prognosis and prediction of lymph node metastasis in bladder urothelial carcinoma.Expression of PLAGL2 in bladder urothelial carcinoma and its relationship to lymph node metastasis and survival.Immunohistochemical and molecular analysis of PI3K/AKT/mTOR pathway in esophageal carcinoma.A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
P2860
Q24300152-45687B65-80DB-4F1A-B7F9-3C3B0CE989CFQ27021371-35E37B2A-C798-4CC6-A9F7-DEAAD8ED6E71Q28477425-CEA70568-A802-486E-AEB9-8E968FDEE730Q28477972-6DAE7957-E6D4-40E3-8CC1-F0321FED8E9CQ33774170-2D53BCF1-25FB-4674-ADB6-F8ACC19AD407Q33922437-2EDC7535-1D6F-497C-AA63-43287F0147DBQ34448168-15C350B5-3A37-4893-8D1F-86ED9A88B0FAQ35151995-EDC5C02B-BA79-440B-AC0B-003820604ED0Q35671292-4FF16606-292A-4A34-974E-9A2F7D5460DAQ36061127-D5FEDBAF-DF40-4641-A7A8-CF65A36E562DQ37091474-591180F2-B699-4FBF-89A2-914D99057C61Q37974674-9B5482D6-FA74-4197-BD85-A7F4599B5B81Q38717560-0123D9E2-4BCA-497C-A4DE-4E4B4AAD213CQ38809335-68C10CFB-5882-4D91-A505-190ADC0DD42DQ39307061-2734CA45-F7AF-4D9F-A268-31FB5CEC2260Q41809618-9500958F-198E-44BC-BF2F-6A41F50BB017Q41913207-50C8E43D-B39F-4900-868A-31E5C0DDE64FQ41984466-1B2FFC85-856D-441A-B3AF-F18C007ACC9EQ45902808-31328038-A4E2-4F87-88E6-5C74588C2A26Q46766883-36089FF4-5FA7-4C4F-BFE0-2299AA595F85Q52338851-49338378-16EF-4BFC-AC85-119216312B59Q52584535-F9A1B51F-D98E-4898-8BC3-B2AA21CA5190Q53220241-B1D555E0-8010-4FA4-B841-4F82D973EAEEQ54285690-09526370-EF19-42AA-888C-04795FCE1FD3
P2860
Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Expression status and prognost ...... nary bladder after cystectomy.
@ast
Expression status and prognost ...... nary bladder after cystectomy.
@en
type
label
Expression status and prognost ...... nary bladder after cystectomy.
@ast
Expression status and prognost ...... nary bladder after cystectomy.
@en
prefLabel
Expression status and prognost ...... nary bladder after cystectomy.
@ast
Expression status and prognost ...... nary bladder after cystectomy.
@en
P2093
P2860
P356
P1433
P1476
Expression status and prognost ...... nary bladder after cystectomy.
@en
P2093
Angelo M DeMarzo
David Sidransky
George J Netto
Jessica Hicks
Luciana Schultz
Mark L Gonzalgo
Mark Schoenberg
Matthew E Nielsen
Roula Albadine
Sana Jadallah
P2860
P304
P356
10.1002/CNCR.25502
P407
P577
2010-10-11T00:00:00Z